Intrasoft Technologies Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 19, 2025, 9:29 pm

Competitors of Intrasoft Technologies Ltd

All Competitor Stocks of Intrasoft Technologies Ltd

Quarterly Result

Last Updated: August 20, 2025, 8:55 am

Below is a detailed analysis of the quarterly data for Intrasoft Technologies Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 128.99 Cr.. The value appears to be declining and may need further review. It has decreased from 130.04 Cr. (Mar 2025) to 128.99 Cr., marking a decrease of 1.05 Cr..
• For Expenses, as of Jun 2025, the value is 124.17 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 126.38 Cr. (Mar 2025) to 124.17 Cr., marking a decrease of 2.21 Cr..
• For Operating Profit, as of Jun 2025, the value is 4.82 Cr.. The value appears strong and on an upward trend. It has increased from 3.66 Cr. (Mar 2025) to 4.82 Cr., marking an increase of 1.16 Cr..
• For OPM %, as of Jun 2025, the value is 3.74%. The value appears strong and on an upward trend. It has increased from 2.81% (Mar 2025) to 3.74%, marking an increase of 0.93%.
• For Other Income, as of Jun 2025, the value is 0.08 Cr.. The value appears to be declining and may need further review. It has decreased from 0.12 Cr. (Mar 2025) to 0.08 Cr., marking a decrease of 0.04 Cr..
• For Interest, as of Jun 2025, the value is 0.33 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.32 Cr. (Mar 2025) to 0.33 Cr., marking an increase of 0.01 Cr..
• For Depreciation, as of Jun 2025, the value is 0.18 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.18 Cr..
• For Profit before tax, as of Jun 2025, the value is 4.39 Cr.. The value appears strong and on an upward trend. It has increased from 3.28 Cr. (Mar 2025) to 4.39 Cr., marking an increase of 1.11 Cr..
• For Tax %, as of Jun 2025, the value is 6.38%. The value appears to be improving (decreasing) as expected. It has decreased from 28.35% (Mar 2025) to 6.38%, marking a decrease of 21.97%.
• For Net Profit, as of Jun 2025, the value is 4.10 Cr.. The value appears strong and on an upward trend. It has increased from 2.35 Cr. (Mar 2025) to 4.10 Cr., marking an increase of 1.75 Cr..
• For EPS in Rs, as of Jun 2025, the value is 2.51. The value appears strong and on an upward trend. It has increased from 1.44 (Mar 2025) to 2.51, marking an increase of 1.07.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 5:08 am

Growth

Last Updated: September 5, 2025, 7:45 am

Balance Sheet

Last Updated: September 10, 2025, 1:52 pm

Below is a detailed analysis of the balance sheet data for Intrasoft Technologies Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 16.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 16.00 Cr..
• For Reserves, as of Mar 2025, the value is 212.00 Cr.. The value appears strong and on an upward trend. It has increased from 195.00 Cr. (Mar 2024) to 212.00 Cr., marking an increase of 17.00 Cr..
• For Borrowings, as of Mar 2025, the value is 13.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 139.00 Cr. (Mar 2024) to 13.00 Cr., marking a decrease of 126.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 25.00 Cr.. The value appears to be improving (decreasing). It has decreased from 27.00 Cr. (Mar 2024) to 25.00 Cr., marking a decrease of 2.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 266.00 Cr.. The value appears to be improving (decreasing). It has decreased from 377.00 Cr. (Mar 2024) to 266.00 Cr., marking a decrease of 111.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 12.00 Cr.. The value appears to be declining and may need further review. It has decreased from 13.00 Cr. (Mar 2024) to 12.00 Cr., marking a decrease of 1.00 Cr..
• For CWIP, as of Mar 2025, the value is 221.00 Cr.. The value appears strong and on an upward trend. It has increased from 180.00 Cr. (Mar 2024) to 221.00 Cr., marking an increase of 41.00 Cr..
• For Investments, as of Mar 2025, the value is 3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 87.00 Cr. (Mar 2024) to 3.00 Cr., marking a decrease of 84.00 Cr..
• For Other Assets, as of Mar 2025, the value is 30.00 Cr.. The value appears to be declining and may need further review. It has decreased from 98.00 Cr. (Mar 2024) to 30.00 Cr., marking a decrease of 68.00 Cr..
• For Total Assets, as of Mar 2025, the value is 266.00 Cr.. The value appears to be declining and may need further review. It has decreased from 377.00 Cr. (Mar 2024) to 266.00 Cr., marking a decrease of 111.00 Cr..

Notably, the Reserves (212.00 Cr.) exceed the Borrowings (13.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Intrasoft Technologies Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 7.78. This value is within the healthy range. It has increased from 6.61 (Mar 24) to 7.78, marking an increase of 1.17.
• For Diluted EPS (Rs.), as of Mar 25, the value is 7.78. This value is within the healthy range. It has increased from 6.61 (Mar 24) to 7.78, marking an increase of 1.17.
• For Cash EPS (Rs.), as of Mar 25, the value is 8.30. This value is within the healthy range. It has increased from 6.61 (Mar 24) to 8.30, marking an increase of 1.69.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 140.08. It has increased from 129.57 (Mar 24) to 140.08, marking an increase of 10.51.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 140.08. It has increased from 129.57 (Mar 24) to 140.08, marking an increase of 10.51.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 310.94. It has increased from 297.62 (Mar 24) to 310.94, marking an increase of 13.32.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 11.63. This value is within the healthy range. It has decreased from 16.46 (Mar 24) to 11.63, marking a decrease of 4.83.
• For PBIT / Share (Rs.), as of Mar 25, the value is 11.11. This value is within the healthy range. It has decreased from 15.86 (Mar 24) to 11.11, marking a decrease of 4.75.
• For PBT / Share (Rs.), as of Mar 25, the value is 9.54. This value is within the healthy range. It has increased from 8.57 (Mar 24) to 9.54, marking an increase of 0.97.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 7.78. This value is within the healthy range. It has increased from 6.01 (Mar 24) to 7.78, marking an increase of 1.77.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 7.78. This value is within the healthy range. It has increased from 6.01 (Mar 24) to 7.78, marking an increase of 1.77.
• For PBDIT Margin (%), as of Mar 25, the value is 3.74. This value is below the healthy minimum of 10. It has decreased from 5.53 (Mar 24) to 3.74, marking a decrease of 1.79.
• For PBIT Margin (%), as of Mar 25, the value is 3.57. This value is below the healthy minimum of 10. It has decreased from 5.32 (Mar 24) to 3.57, marking a decrease of 1.75.
• For PBT Margin (%), as of Mar 25, the value is 3.06. This value is below the healthy minimum of 10. It has increased from 2.88 (Mar 24) to 3.06, marking an increase of 0.18.
• For Net Profit Margin (%), as of Mar 25, the value is 2.50. This value is below the healthy minimum of 5. It has increased from 2.01 (Mar 24) to 2.50, marking an increase of 0.49.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 2.50. This value is below the healthy minimum of 8. It has increased from 2.01 (Mar 24) to 2.50, marking an increase of 0.49.
• For Return on Networth / Equity (%), as of Mar 25, the value is 5.55. This value is below the healthy minimum of 15. It has increased from 4.63 (Mar 24) to 5.55, marking an increase of 0.92.
• For Return on Capital Employeed (%), as of Mar 25, the value is 7.03. This value is below the healthy minimum of 10. It has decreased from 7.05 (Mar 24) to 7.03, marking a decrease of 0.02.
• For Return On Assets (%), as of Mar 25, the value is 4.48. This value is below the healthy minimum of 5. It has increased from 2.49 (Mar 24) to 4.48, marking an increase of 1.99.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 0.2. It has decreased from 0.65 (Mar 24) to 0.04, marking a decrease of 0.61.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.05. This value is within the healthy range. It has decreased from 0.65 (Mar 24) to 0.05, marking a decrease of 0.60.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.50. It has increased from 1.27 (Mar 24) to 1.50, marking an increase of 0.23.
• For Current Ratio (X), as of Mar 25, the value is 1.29. This value is below the healthy minimum of 1.5. It has decreased from 6.49 (Mar 24) to 1.29, marking a decrease of 5.20.
• For Quick Ratio (X), as of Mar 25, the value is 0.52. This value is below the healthy minimum of 1. It has decreased from 3.15 (Mar 24) to 0.52, marking a decrease of 2.63.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 9.60. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 9.60, marking an increase of 9.60.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 7.43. This value is within the healthy range. It has increased from 2.26 (Mar 24) to 7.43, marking an increase of 5.17.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 5.96. This value is within the healthy range. It has increased from 1.82 (Mar 24) to 5.96, marking an increase of 4.14.
• For Enterprise Value (Cr.), as of Mar 25, the value is 160.09. It has decreased from 314.88 (Mar 24) to 160.09, marking a decrease of 154.79.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.31. This value is below the healthy minimum of 1. It has decreased from 0.64 (Mar 24) to 0.31, marking a decrease of 0.33.
• For EV / EBITDA (X), as of Mar 25, the value is 8.44. This value is within the healthy range. It has decreased from 11.73 (Mar 24) to 8.44, marking a decrease of 3.29.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.29. This value is below the healthy minimum of 1. It has decreased from 0.36 (Mar 24) to 0.29, marking a decrease of 0.07.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Price / BV (X), as of Mar 25, the value is 0.66. This value is below the healthy minimum of 1. It has decreased from 0.84 (Mar 24) to 0.66, marking a decrease of 0.18.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.29. This value is below the healthy minimum of 1. It has decreased from 0.36 (Mar 24) to 0.29, marking a decrease of 0.07.
• For EarningsYield, as of Mar 25, the value is 0.08. This value is below the healthy minimum of 5. It has increased from 0.05 (Mar 24) to 0.08, marking an increase of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness